Avid Bioservices Inc

NAS:CDMO   3:59PM EDT
7.33
+0.06 (+0.83%)
StockTwits Share  Twitter Share  Facebook Share

Search For a Symbol

Market Cap (Intraday)412.26M
Current PEN/A
Forward PE N/A
2yr Forward PE 183.25
See more stats...
Estimates Current Quarter
Revenue$15.42 Million
Adjusted EPS-$0.04
See more estimates...
10-Day MA$6.32
50-Day MA$5.43
200-Day MA$5.13
See more pivots...

Avid Bioservices, Inc. Stock, NAS:CDMO

2642 MICHELLE DRIVE, SUITE 200, TUSTIN, CA 92780
United States of America
Phone: 714.508.6100
Number of Employees: 281

Description

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops monoclonal antibodies for the treatment of cancer in the United States. It's lead immunotherapy candidate bavituximab, a monoclonal antibody that targets and binds to phosphatidylserine. The company also provides integrated current good manufacturing practices services from cell line development to commercial bio manufacturing for its third-party customers. In addition, its services comprise cGMP clinical and commercial manufacturing utilizing stainless steel and single use bioreactor technology, purification, bulk packaging, stability testing, regulatory strategy and related support. The company has license agreements with the University of Texas Southwestern Medical Center at Dallas; Genentech, Inc.; Avanir Pharmaceuticals, Inc.; Lonza Biologics; Affitech A/S; Merck KGaA; and National Comprehensive Cancer Network, as well as collaboration agreement with AstraZeneca PLC and Memorial Sloan Kettering Cancer Center. Peregrine Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Tustin, California.